Envestnet Portfolio Solutions Inc. Sells 1,281 Shares of Humana Inc. $HUM

Envestnet Portfolio Solutions Inc. trimmed its stake in Humana Inc. (NYSE:HUM) by 56.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,008 shares of the insurance provider’s stock after selling 1,281 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Humana were worth $246,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HUM. Revolve Wealth Partners LLC bought a new stake in shares of Humana in the 4th quarter worth about $202,000. GAMMA Investing LLC grew its stake in Humana by 54.9% during the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider’s stock worth $781,000 after buying an additional 1,046 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Humana by 144.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,734 shares of the insurance provider’s stock worth $4,163,000 after buying an additional 9,296 shares in the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Humana during the first quarter worth approximately $1,309,000. Finally, Cambridge Investment Research Advisors Inc. raised its stake in shares of Humana by 3.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,608 shares of the insurance provider’s stock valued at $1,219,000 after acquiring an additional 145 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HUM shares. Wolfe Research raised their price target on Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a report on Monday, October 6th. Bank of America raised their target price on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a report on Friday, October 3rd. Evercore ISI began coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price objective on the stock. Finally, Truist Financial set a $300.00 price objective on shares of Humana in a research report on Tuesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $297.58.

Humana Price Performance

Humana stock opened at $290.66 on Friday. The business’s 50-day simple moving average is $281.65 and its 200 day simple moving average is $259.12. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market cap of $34.96 billion, a price-to-earnings ratio of 22.31, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s dividend payout ratio (DPR) is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.